Gene expression profiling of peripheral blood cells for early detection of breast cancer

Abstract

IntroductionEarly detection of breast cancer is key to successful treatment and patient survival. We have previously reported the potential use of gene expression profiling of peripheral blood cells for early detection of breast cancer. The aim of the present study was to refine these findings using a larger sample size and a commercially available microarray platform.MethodsBlood samples were collected from 121 females referred for diagnostic mammography following an initial suspicious screening mammogram. Diagnostic work-up revealed that 67 of these women had breast cancer while 54 had no malignant disease. Additionally, nine samples from six healthy female controls were included. Gene expression analyses were conducted using high density oligonucleotide microarrays. Partial Least Squares Regression (PLSR) was used for model building while a leave-one-out (LOO) double cross validation approach was used to identify predictors and estimate their prediction efficiency.ResultsA set of 738 probes that discriminated breast cancer and non-breast cancer samples was identified. By cross validation we achieved an estimated prediction accuracy of 79.5% with a sensitivity of 80.6% and a specificity of 78.3%. The genes deregulated in blood of breast cancer patients are related to functional processes such as defense response, translation, and various metabolic processes, such as lipid- and steroid metabolism.ConclusionsWe have identified a gene signature in whole blood that classifies breast cancer patients and healthy women with good accuracy supporting our previous findings.

RNA-Stabilized Whole Blood Samples but Not Peripheral Blood Mononuclear Cells Can Be Stored for Prolonged Time Periods Prior to Transcriptome Analysis

“…Moreover, it has been suggested that blood-based GEP can be used as a powerful tool for early diagnosis of certain solid cancer entities, [32][33][34][35][36] as well as infectious, 37,38 autoimmune, 39,40 and neurodegenerative 41 disease. Nevertheless, prospective clinical studies are still needed to validate these promising but still preliminary results in larger cohorts of patients or in individuals at risk for the respective diseases.…”

Gene expression profiles in febrile children with defined viral and bacterial infection

“…In addition, specific blood transcriptional signatures were defined in adult volunteers challenged with specific respiratory viruses (11). Analysis of host transcriptional profiles has also been applied to the diagnosis of inflammatory and hematological diseases (12)(13)(14)(15), including the identification of potential biomarkers for specific disease entities (5).…”

Exosomes as divine messengers: are they the Hermes of modern molecular oncology?

“…75 It would be very useful to develop new mechanisms to monitor the transcriptome expression pattern based on the use of noninvasive biological fluids. [76][77][78] As the composition of nucleic acids (specifically RNA) reflect in most cases the nature and origin of the parental cell, exosomes may be considered valuable carriers of cell-specific information because their content provides an insight glance of the proteins being transcribed in the original tissue. [79][80][81] In this manner, exosomes may be used in the clinic to achieve early diagnostics and prognosis information, but also to stratify and separate patients into different clinical categories in order to determine specific targeted therapies.…”